SynthesisFrontiers in immunology2021

Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis.

Qingyu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.